Drug makers may shift R&D focus to 'more

BOSTON -- The search by brand-name drug companies for a new generation of b blockbuster drugs may give way to the development of medicines that could be more modest in scope but that produce

Tobacco Money at the University of

Like many health sciences institutions around the world (1, 2), six academic units throughout the 10-campus University of California system have adopted policies not to accept

Development costs still rise, but success is

BOSTON -- With scarcely more than 1-in-5 new drug compounds that reach human testing stage actually passing all the way through the testing and review gauntlet,